Skip to main content

Animations

MJFF Publications

6471 - 6480 of 9117 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2023
  • 2024
  • 2024
  • 2024
  • 2024
  • 2025
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Temporal control of acute protein aggregate turnover by UBE3C and NRF1-dependent proteasomal pathways
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2417390121
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30019
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91083
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00840-w
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.99914
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's disease
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cts.70111
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Pharmacological targeting of dopamine D1 or D2 receptors evokes a rapid‐onset parkinsonian motor phenotype in mice
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16622
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The Exon-Based Transcriptomic Analysis of Parkinson’s Disease
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom15030440
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00896-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00841-9
    Citation Count: 18
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.